The minimal inhibitory concentrations of piperacillin and seven other betalactam antibiotics were determined against 407 bacterial isolates. Piperacillin was found to be more active than ampicillin against susceptible gram-negative bacilli and more active than either carbenicillin or ticarcillin against Pseudomonas aeruginosa and streptococci. Although piperacillin was active against Klebsiella pneumoniae, this activity was less than that of the cephalosporins. Piperacillin was not active against penicillin-resistant Staphylococcus aureus and Enterobacteriaceae that were resistant to the other test antibiotics.
Piperacillin is a new semisynthetic derivative of aminobenzylpenicillin which has an antibacterial spectrum that is wider than any of the available penicillins or cephalosporins. We compared the in vitro activity of piperacillin with that of benzylpenicillin, amipicillin, carbenicilhin, ticarcillin, cephalothin, cefazolin, and cefamandole against a variety of gram-positive and gramnegative bacteria. We also evaluated the activity of piperacillin against isolates selected because of their known resistance to other test antibiotics.
The organisms tested were recent clinical isolates that had been identified by standard microbiological procedure by biochemical methods (1, 8, 11) . Minimal inhibitory concentrations (MICs) were determined by the agar plate diffusion method of Ericsson and Sherris (2) . Aerobic isolates were tested on Mueller-Hinton agar; this medium was supplemented with 5% sheep blood for streptococcal isolates. Anaerobic isolates were tested with brucella medium supplemented with 5% laked sheep blood and vitamin K (10 ,ug/ml) (11) . Para-nitrophenyl glycerine (0.2 mM) was added to the test agar to inhibit the spreading of Proteus species (7). The inoculum was prepared from an overnight broth culture of the organism, and the turbidity was adjusted to a known standard and applied to the plates by a Steers replicator (10 (5) . Isolates that were not inhibited by the highest concentration of antibiotic used to test susceptibility were considered separately.
The mean MICs of the various antibiotics against the species of Streptococcus and gramnegative bacilli are shown in Table 1 . Piperacillin was more active than either carbenicillin or ticarcillin against each species of streptococci. In addition, piperacillin was more active against Streptococcus pneumoniae, Group A streptococci, and group D streptococci than were the cephalosporins, with the exception of cefamandole against group A streptococci. The cephalosporins were active against all 29 test isolates of S. aureus, including 24 (83%) which were resistant to penicillin. The mean MICs of cephalothin, cefamandole, and cefazolin were 0.5, 0.7, and 1.0 ,ug/ml, respectively. Although penicillin-susceptible S. aureus were inhibited by piperacillin at concentrations of 0.8 to 1.6 ,Lg/ml, penicillinresistant isolates resisted the activity of piperacillin (median MIC = 25 ,ug/ml).
The mean MIC of piperacillin against ampicillin-susceptible isolates of E. coli was twofold lower than that of ampicillin. Only cefamandole had more potent activity against these organisms when compared with piperacillin. The activity of piperacillin against antibiotic-resistant gram-negative bacilli is presented in Table  2 . Half of the ampicillin-resistant E. coli were inhibited by piperacillin at a concentration of 100 ,ug/ml.
Twenty-eight (90%) of 31 K. pneumoniae iso-ANTIMICROB. AGENTS CHEMOTHER. Although Proteus mirabilis isolates were susceptible to all of the antibiotics studied, piperacillin was the most active agent. Twenty-one (81%) of 26 indole-positive Proteus species were susceptible to carbenicillin, ticarcillin, piperacillin, and cefamandole. The activity of piperacillin against these indole-positive Proteus isolates did not differ from that of either carbenicillin or ticarcillin, but was threefold greater than that of cefamandole.
Thirty-nine of 51 isolates of P. aeruginosa were susceptible to carbenicillin. The mean MIC of piperacillin against these isolates was eightfold lower than the mean MIC of carbenicillin and fourfold lower than the mean MIC of ticarcillin. In addition, 11 of the 12 carbenicillin-resistant P. aeruginosa were inhibited by 100 ,Ig or less of piperacillin per ml. (Table 2) .
Fourteen (93%) of 15 test isolates of Bacteroides fragilis were susceptible to piperacillin. 
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The activity of this antibiotic against B. fragilis was comparable to that of any of the other penicillin derivatives (Table 1) . Cefoxitin was also included in the testing of these isolates; the mean MIC of cefoxitin did not differ (P < 0.05) from that of piperacillin.
Piperacillin has been found to have a broader spectrum of antimicrobial activity than any of the other currently available penicillin antibiotics. A unique property of this new agent is its activity against K. pneumoniae, an organism which tends to be highly resistant to the other penicillin antibiotics. Susceptible K. pneumoniae are inhibited by piperacillin at a mean concentration that is approximately 20-fold less than the peak serum levels obtained with this drug. The other gram-negative enteric organisms including P. aeruginosa were susceptible to even lower concentrations of piperacillin. Piperacillin, on a weight basis, is more active than ampicillin against E. coli and P. mirabilis. Its activity against Enterobacter, indole-positive Proteus, and S. marcescens is comparable to that of either carbenicillin or ticarcillin. Most strains of B. fragilis are also susceptible to achievable concentrations of piperacillin. The activity of piperacillin against gram-positive cocci appears to be comparable to that of benzylpenicillin and greater than that of either carbenicillin or ticarcillin. These findings are in agreement with those of Ueo et al. (12) and confirm the results of other studies (2-4, 6, 9, 13, 14) .
The antibacterial spectrum of piperacillin differs from that of cephalosporins. Although cefamandole is the cephalosporin with the broadest spectrum of activity, it is not active against P. aeruginosa and S. marcescens. In addition, the activity of the cephalosporins against B. fragilis and enterococci is limited. The cephalosporins, however, are active against penicillinase-producing S. aureus, whereas piperacillin is inactivated by staphylococcal penicillinase (12) . Some strains of E. coli that are resistant to ampicillin are susceptible to piperacillin. Our findings that K. pneumoniae isolates resistant to cephalothin were also resistant to piperacillin is in contrast with the findings of Verbist, who reported no correlation between the resistance of K. pneumoniae to cephalothin and to piperacillin (14) .
The findings of this study indicate that piperacillin has potential value in the management of many types of serious community-acquired infections. The organisms that cause these infections, with the exception of S. aureus, are likely to be susceptible to piperacillin. Piperacillin may also be a useful drug for the treatment of serious P. aeruginosa infections because ofits enhanced activity against this organism.
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